Leymus Genomics partners with NVIDIA with focus on AI & WGS data analysis

Leymus Genomics partners with NVIDIA with focus on AI & WGS data analysis

Bioinformatics for whole genome sequencing data.

Leymus Genomics is excited to start collaborating with NVDIA. Our focus is on whole-genome sequencing data and associated health data.

You might be familiar with NVIDIA’s GEFORCE graphic cards for computer games – NVIDIA is developing GPUs for most of the computers and scientists in the world working with AI and parallel computing.

Sequencing analyses of whole human genes benefit by using NVIDIA CUDA-enabled GPUs. There is now progress on using GPUs for a range of bioinformatics and life sciences codes.

Leymus Genomics supports and collaborates with Parabricks WGS secondary analysis program for the GATK pipeline running on CUDA cores from NVIDIA. With Parabricks you can expect to speed up your analysis time with 30-50x*. We would like to talk to you if you are about to analyze >100 human genomes and you can see speed and data infrastructure as potential issues.

* This depends on the data infrastructure and number of CPUs at the genomic site.


Leymus Genomics onboards new data scientists

Leymus Genomics onboards new data scientists

Leymus Genomics is very happy to welcome our two new data scientists and partners, Niels Buus Lassen and René Madsen, to our team. This will further our goals of providing world leading data solutions for medium to very large scale genomic labs. Niels and René bring a combined 30 years of working with complex statistical modeling, machine learning, AI, deep learning and developing enterprise software to the company. The addition to the team will open up opportunities for Leymus Genomics to work with data intensive challenges in the genomics field. We are interested in further partnerships in the development of better models for analysing large data sets of genomic data. Leymus Genomics can today provide the full workflow from on-site data storage (DDN), GPUs to accelerate your analysis (official announcement on Monday Oct 8th), WGS secondary analysis on GPUs (Parabricks), and AI consulting and development.


New Partnership with Parabricks

New Partnership with Parabricks

High Performance Secondary Analysis of Genomic Data

Leymus Genomics are happy to announce our partnership with Parabricks, the first to bring secondary analysis with GATK to GPUs in the cloud or local with NVIDIA.

Parabricks provides 30-50 times faster secondary analysis of FASTQ files coming out of sequencers to VCF files that have the variants for tertiary analysis. Parabricks accelerates existing GATK best practices to generate equivalent results as the baseline CPU-only solution.

  • Turnkey Solution: Parabricks software runs on standard CPU and GPU nodes available on the cloud and requires no additional setup steps by the user.
  • On-Premise and Cloud Agnostic: The Parabricks software can run on local servers like DGX-1 servers or public cloud such as AWS, Google Cloud Services and Microsoft Azure.
  • 100% Deterministic and Reproducible: Any configuration of Parabricks software on any platform with any number of resources, generates the exact same results every execution.
  • Equivalent results: Parabricks’ pipeline generates equivalent results as baseline GATK 4 best practices pipeline as the same algorithm is used.

 

Website

https://www.parabricks.com/


NGS Service lab for Scandinavian researchers

We are happy to celebrate our 1 year anniversary since going live at ESHG on the 27th of May in Copenhagen in 2017. To celebrate this we will have a NGS/Microarray service lab campaign from the 1st of May to the 30th of June.

RNA Seq*
249 € per sample

Illumina EPIC 850K Methylation Array**
315 € per sample

RNA Seq + Illumina EPIC 850K Methylation Array***
559 € per sample

Exome Seq****
399 € per sample

* 15 Mill reads min of 48 samples

** Min of 96 samples, High quality samples. If FFPE samples there will be an add-on fee.

*** Min 48 samples 15 Mill reads per sample for RNA seq

 **** Min 96 samples, 16 million reads

This is a time-limited campaign which expires August 31stst, 2018

GenomeScan one of the first NGS service labs in the world – a leader in Genomic analysis – from sample to analysis:

  • GLP and ISO/IEC 17025 (L518) accredited
  • NGS platforms includes HiSeq 4000, HiSeq 2500, Nextseq 500, PacBio, 10x (Chromium platform)
  • Transcriptomics, Epigenetics, Single cell seq., WGS, WES
  • From sample to bioinformatics analysis
  • R&D facility provides the most cutting-edge techniques
  • Industry leading turnaround time
  • Leymus Genomics will be your local partner in discussing the right approach for your next NGS project. We provide full NGS service for the Nordic countries in collaboration with GenomeScan


Leymus Genomics went live at ESHG 2017

Thank you for all the interesting discussions at ESHG. Pictures from Leymus at ESHG, International High Performance Computing in Frankfurt, and DSKB 2017 (Danish Society for Clinical Biochemistry). We learned that several of our solutions around the NGS workflow – e.g. DDN Data storage and BioDynami NGS library prep – are faster and more simple than existing solutions. We look forward to seeing you in your lab.


New Partnership with GenomeScan

Leymus Genomics is the exclusive supplier of GenomeScan services to Sweden, Denmark, Norway, Finland and Iceland.
GenomeScan was one of the first service labs in Europe and is a leader in DNA analysis from Sample to Bioinformatics:

  • ISO/IEC 17025 (L518) accredited
  • NGS platforms such as HiSeq 4000, HiSeq 2500, Nextseq 500,  PacBio Sequel, Chromium
  • Transcriptomics, Epigenetics, Single cell seq., WGS, WES
  • R&D facility provides the most cutting-edge techniques
  • Fast turnaround time when needed.

Leymus Genomics will be your local partner in discussing the right approach for your next NGS project. We in collaboration with Genomescan provide full NGS service for the Nordic countries.

The projects are run in a technology and pipeline agnostic manner.

Website

www.genomescan.nl


Leymus Genomics and DDN signs Life Science Data storage agreement for the Nordic countries

Leymus Genomics and DDN has signed a Life Science Data storage agreement for the Nordic countries. Leymus Genomics is excited to partner up with the leader in local large scale data storage solutions.

DataDirect Networks, Inc. (DDN) is the world’s leading big data storage supplier to data-intensive, global organizations. For more than 18 years, DDN has developed, deployed and optimized systems, software and storage solutions that enable enterprises, service providers, research and government agencies to generate more value and to accelerate time to insight from their data, on premise and in the cloud. Organizations leverage the power of DDN storage technology and the deep technical expertise of its team to capture, store, analyze, collaborate and distribute information and content at the largest scale in the most efficient, reliable and cost-effective manner. DDN customers include many of the world’s leading healthcare and life science organizations, manufacturing and energy companies, government and research facilities, and web and cloud service providers.


New partnership with SensoQuest producer of maybe best performing PCR cycler on the market

It is with great pleasure we can announce the partnership with SensoQuest. Expectations are high for being able to deliver one of the best PCR cyclers on the market. When it goes to delivering on the specifications these state-of-the-art PCR Instruments comes with the highest recommendations from scientists. The agreement covers the following countries Norway, Iceland, Sweden and Finland.

 

Are you interested in testing this instrument Leymus Genomics has a demo system that can be tested.


Leymus has started a commercial partnership with Claremont Biosolutions

We are happy to announce that Leymus Genomics has started a commercial partnership with Claremont Biosolutions. The agreement covers exclusive sales of the entire product portfolio for Norway, Denmark, Iceland, Finland, Sweden and Germany. Claremont Biosolutions has developed a family of proprietary products for the ultra-fast mechanical lysis of cells, the extraction and purification of genomic DNA, and the cost-effective, real-time detection of amplified DNA sequences. Claremont BioSolutions has focused on developing products that combine speed with ease-of-use.

Read more